| Table 1: Pharmacologic enzyme inhibitors. |
| | Inhibitor | Specificity | Route | Reference |
| | L-NAME | Nonselective NOS | Oral | [20, 42, 43] | | NOHA | Arginase | Inhaled | [39, 44, 45] | | nor-NOHA | Arginase | Inhaled, intraperitoneal | [19, 38, 42, 46, 47] | | L-NMMA | Arginase | Inhaled | [48] | | ABH | Arginase | Inhaled | [49] | | BEC | Arginase | Oropharyngeal aspiration | [50] |
|
|
List of abbreviations: N (G-) nitro-L-arginine methyl ester (L-NAME), nitric oxide synthase (NOS), N-hydroxy-L-arginine (NOHA), N-hydroxy-nor-L-arginine (nor-NOHA), NG-monomethyl-L-arginine (L-NMMA), 2(S)-amino-6-boronohexanoic acid (ABH), S-(2-boronoethyl)-l-cysteine (BEC).
|